google-site-verification: googlec7193c3de77668c9.html

A routine blood test could help predict who benefits most from CAR T-cell therapy

[
Measuring the lymphocytes—white blood cells that fight infection—in a patient’s blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to research from physicians at Fox Chase Cancer Center and Temple Health.


Source link

Advertisements
Views: 2

See also  Insulin and metformin combo aids diabetic foot ulcer healing, new study finds

Check Also

Simulation-guided search uncovers two promising tuberculosis drug candidates targeting CYP

[ A research team led by Associate Professor Noriyuki Kurita from the Department of Computer …

Why your wearable health tracker can make you feel anxious

[ Millions of people use a wearable health and fitness tracker. These devices can be …

Why metformin matters beyond diabetes: New target could reshape aging and cancer research

[ Scientists at Université de Montréal have figured out how metformin—a common drug that’s used …

Leave a Reply

Available for Amazon Prime
Making digital tools accessible for everyone.